AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 3.220
0.00 (0.00%)
Oct 14, 2026, 5:18 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 68.15 million as of October 14, 2026. It is the 43,647th most valuable company in the world and the 650th biggest in Sweden. Its market cap has increased by 11.03% in one year.
Market Cap
68.15M
Enterprise Value
58.67M
Revenue
9.31M
Global Rank
Country Rank
#650 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since January 9, 2017, AcouSort AB's market cap has increased from 65.36M to 68.15M, an increase of 4.27%. That is a compound annual growth rate of 0.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 68.15M | 13.78% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xintela AB | 121.87M |
| NextCell Pharma AB | 121.34M |
| OncoZenge AB | 96.74M |
| Active Biotech AB | 87.78M |
| Biovica International AB | 85.53M |
| Spago Nanomedical AB | 83.03M |
| Nanologica AB | 82.85M |
| Ascelia Pharma AB | 81.46M |